Share

April 18, 2017; 88 (16) Article

Feasibility and accuracy of teleconcussion for acute evaluation of suspected concussion

Bert B. Vargas, Morgan Shepard, Joseph G. Hentz, Cherisse Kutyreff, L. George Hershey, Amaal J. Starling
First published March 24, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003841
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1352

Share

Article Information

vol. 88 no. 16 1580-1583
DOI: 
https://doi.org/10.1212/WNL.0000000000003841
PubMed: 
28341642
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 17, 2016
  • Accepted in final form January 24, 2017
  • First Published March 24, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Bert B. Vargas, MD,
    2. Morgan Shepard, BS,
    3. Joseph G. Hentz, MS,
    4. Cherisse Kutyreff, ATC,
    5. L. George Hershey, DO and
    6. Amaal J. Starling, MD
  1. Bert B. Vargas, MD,
    2. Scientific Advisory Boards:

    1. (1) Allergan, (2) Zogenix, (3) Pernix, (4) Alder, (5) Avanir, (6) Lilly

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) American Headache Society

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. (1) Avanir

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) Mayo Clinic

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Morgan Shepard, BS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Joseph G. Hentz, MS,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) PCORI, PCS-1504-30133, Statistician, 2016-2021, (2) NINDS, 1U24NS072026, Statistician, 2011-2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Migraine Research Foundation, (2) Arizona Alzheimer's Consortium, (3) Michael J Fox Foundation, (4) American Hearth Association, (5) Arizona Alzheimer's Research Center.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Cherisse Kutyreff, ATC,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. L. George Hershey, DO and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Amaal J. Starling, MD
    7. Scientific Advisory Boards:

    1. (1) Amgen (2) eNeura

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) eNeura

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology and Neurotherapeutics (B.B.V.), University of Texas Southwestern Medical Center, Dallas; Departments of Neurology (M.S., A.J.S.) and Biostatistics (J.G.H.), Mayo Clinic in Arizona, Scottsdale; and Department of Sports Medicine (C.K., L.G.H.), Northern Arizona University, Flagstaff.
  1. Correspondence to Dr. Vargas: bert.vargas{at}UTSouthwestern.edu

Article usage

Article usage: March 2017 to November 2023

AbstractFullPdfSource
Mar 2017904015Highwire
Apr 201719041538Highwire
May 20173955432Highwire
Jun 20171543322Highwire
Jul 20171435714Highwire
Aug 2017782519Highwire
Sep 20171233723Highwire
Oct 20171172523Highwire
Nov 20171162113Highwire
Dec 2017724218Highwire
Jan 20181052920Highwire
Feb 2018615221Highwire
Mar 201877286Highwire
Apr 2018752319Highwire
May 2018593511Highwire
Jun 20181393516Highwire
Jul 2018544816Highwire
Aug 2018523710Highwire
Sep 2018532460Highwire
Oct 2018592730Highwire
Nov 2018594423Highwire
Dec 20181152621Highwire
Jan 201956327Highwire
Feb 2019643015Highwire
Mar 2019583859Highwire
Apr 2019513513Highwire
May 2019552415Highwire
Jun 2019441714Highwire
Jul 2019541823Highwire
Aug 2019321811Highwire
Sep 2019131810Highwire
Oct 2019234111Highwire
Nov 2019174814Highwire
Dec 2019281417Highwire
Jan 202011228Highwire
Feb 2020112012Highwire
Mar 2020242519Highwire
Apr 2020214848Highwire
May 2020193118Highwire
Jun 2020132834Highwire
Jul 202018177Highwire
Aug 202062510Highwire
Sep 2020123616Highwire
Oct 2020162618Highwire
Nov 2020121929Highwire
Dec 2020212612Highwire
Jan 202182117Highwire
Feb 202192723Highwire
Mar 202119357Highwire
Apr 2021134110Highwire
May 2021252810Highwire
Jun 202112177Highwire
Jul 2021102826Highwire
Aug 202183511Highwire
Sep 202114299Highwire
Oct 2021132824Highwire
Nov 2021341924Highwire
Dec 2021273014Highwire
Jan 2022183321Highwire
Feb 20226377Highwire
Mar 2022102114Highwire
Apr 202214358Highwire
May 2022112614Highwire
Jun 2022151318Highwire
Jul 202224116Highwire
Aug 202291815Highwire
Sep 2022122013Highwire
Oct 2022422917Highwire
Nov 2022418523Highwire
Dec 2022415316Highwire
Jan 202341665Highwire
Feb 20232914210Highwire
Mar 202337484Highwire
Apr 2023305311Highwire
May 2023295110Highwire
Jun 2023234510Highwire
Jul 202313439Highwire
Aug 2023176513Highwire
Sep 202314536Highwire
Oct 202318514Highwire
Nov 202318676Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles